Canadian PE and VC deal volume fell in early 2026 as capital concentrated into larger transactions.

The pattern is not a funding rebound. It is a selection process. Capital is moving toward companies with scale, infrastructure, or a clear path to cash generation.

The Canadian market split in two

Private equity deployed $12.7 billion across 252 Canadian deals in H1 2026. That was a 59% decline from the $31 billion across 332 deals recorded in the same period of 2025.

The comparison with 2025 is distorted by a strong prior-year market. Against the first halves of 2023 and 2024, the dollar totals look less severe: $5.6 billion and $8.6 billion, respectively. The operational conclusion is simple. Private equity has not left Canada. It has reduced transaction count and increased concentration.

Four take-private transactions accounted for 57% of total private-equity capital deployed:

• Dentalcorp Holdings
• Information Services Corp.
• ECN Capital
• Blackline Safety

The market therefore produced a headline number that hides the mechanics. A small number of large transactions set the aggregate total. For founders, this means median access to capital may be weaker than the headline dollar figure suggests.

Venture capital showed a different pattern. Canadian VC firms invested $2.7 billion, up 17% year over year, while the number of deals fell by roughly 9% to 250. This was the first H1 increase in Canadian VC investment versus the prior year since 2021, according to the Canadian Venture Capital Association.

The largest early-stage transaction was a $139 million financing for Ontario-based Dominion Dynamics. The deal was also described as the largest Series A financing for a Canadian defence startup.

Investors are buying proof, not optionality

KPMG’s Q2 2026 private-equity report describes the same pattern at US and global scale: lower deal volume, stable investment value, and a preference for larger transactions.

By mid-2026, global private-equity investment had reached $1 trillion, while US investment stood at $545.1 billion. US deal volume was 3,926 transactions, versus 9,350 for full-year 2025. The periods are not equivalent, so the comparison does not establish a full-year decline. It does show the pace of deployment and the concentration of capital.

KPMG identifies three target areas in the largest US deals:

• AI infrastructure
• Energy
• Industrial manufacturing

The report also points to a shift away from the traditional software playbook. Investors are allocating toward AI-native companies, data centers, silicon, and energy grids. Legacy SaaS portfolios are facing valuation pressure as the economics of software change.

The practical filter for a startup is now narrower:

• Does the company have infrastructure relevance?
• Can revenue growth be supported by measurable demand?
• Is the business resilient across a financing cycle?
• Can the investor underwrite a path to scale without relying on a higher next-round valuation?

The Canadian data adds another constraint. Foreign investors participated in 56% of later-stage VC funding deals in H1 2026, up from 30% a year earlier. That increases the importance of international readiness for companies seeking larger rounds. It also means domestic founders are competing for capital in a wider market, not only with local peers.

The same diligence logic applies beyond software. A founder building a hardware, fitness, or outdoor business should track unit economics, capital intensity, and repeat demand with the same discipline used in a financing deck. Resources covering trail running and outdoor workouts are relevant only at the operating level; they do not replace evidence of market scale.

What founders should check before fundraising

The current data does not support a generic “capital is back” narrative. It supports a more specific conclusion: capital is available for companies that fit an investor’s conviction threshold.

Before opening a round, management should separate three figures:

1. Total market capital. Large aggregate investment numbers can be driven by a few transactions.

2. Deal count. Falling volume indicates that more companies are being rejected, delayed, or combined into larger financings.

3. Investor mix. The rise in foreign participation matters for later-stage companies that need cross-border distribution, governance, and reporting capacity.

Valuation should be treated as an output of those constraints. A company with stronger revenue growth but weak capital efficiency may still lose to a slower business with infrastructure exposure, clear demand, and lower execution risk.

Verdict: viable for scaled, defensible companies; hostile for undifferentiated startups. The money exists. The average deal does not.